33 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
-201-689-8560 (international) and use conference ID 13743026. To access the webcast presentation, please click here.
A replay of the webcast
6-K
EX-99.2
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
(international) and use conference ID 13742753. To access the webcast presentation, please click here.
A replay of the webcast and accompanying
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
”, with respect to a Party, shall mean the possession of such Party of the ability to grant a license, sublicense, a right to access, a right to use, or other … by the Applicable Laws, reasonable access to all Product Data and results, generated or obtained by or on behalf of and Controlled by Licensee or its
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
have been prepared with the presumption that users of the unaudited interim condensed consolidated financial statements have read or have access
6-K
wsnfplu qd
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
F-3/A
3izy6vs 7vl2
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
2setx
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
7st7ayay wv
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
EX-1.2
lntek
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-4.13
sk7iijctd15h
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-1.1
sv3jv4xsuzuasok2aiql
31 Mar 22
Annual report (foreign)
4:33pm
20-F
06m040czut1luk6
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
75ud3 grijpl
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
424B4
0wcz n056svxf0z5hfpy
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
cljqq6y881ohgt5jwm9z
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
v9le2lcbmnu
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
c5cku040
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-10.2
eu278adl
12 Mar 21
Registration statement (foreign) (amended)
5:02pm